Newsfeeds - Spark Newswire

6 minute read

Psyched: 9 US Reform Bills, Ayahuasca ‘A Release’ For Prince Harry, At-Home Therapy & More

Today, 3:00 AM

Psychedelics Bills Around The Country: 9 New Proposals, Several Passes, Several Fails And A Successful Local Decriminalization Throughout the 2023 session, numerous discussions have been held and various measures have been considered around the legalization of psychedelics. Let’s go over the latest proposed regulations.

AGNPF

2 minute read

Braxia Scientific’s Q3 2023 Finances, Update On Upcoming Acquisition With Irwin Naturals

By Lara Goldstein

Today, 3:00 AM

Research and telemedicine company Braxia Scientific Corp. (OTC: BRAXF) has filed its financial statements for the third quarter ended Dec.

BRAXF

2 minute read

Irwin Naturals Acquires Ketamine Clinic In Kentucky Adding $3M In Projected EBITDA

By Vuk Zdinjak

Today, 3:00 AM

Irwin Naturals Inc. (OTCQB: IWINF) (CSE:IWIN) (FRA:97X) has successfully completed the acquisition of Serenity Health, LLC, a ketamine clinic in Louisville, KY. The agreement with Serenity was initially announced November 30, 2022.

BRAXF

3 minute read

Irwin Naturals Signs LOI To Acquire Braxia Scientific Expanding Its Network Of Mental Health Clinics

By Vuk Zdinjak

Today, 3:00 AM

Irwin Naturals Inc.

BRAXF

4 minute read

6 Psychedelics Companies Take Action: Here Are The Latest, Major Announcements

By Lara Goldstein

Today, 3:00 AM

Second week of 2023, and business is up and running. Let’s take a look at the announcements shared by some of the companies in the psychedelics space.

BRAXF

4 minute read

Psyched: Fed Guidelines And Research Production Quotas, Protests In Canada, Cal’s Decrim Project

By Lara Goldstein

Today, 3:00 AM

Psychedelic Research & Fed Funding By The National Institute Of Mental Health The National Institute of Mental Health (NIMH) named the types of psychedelics studies to which it would grant funds and further guidance for pre-clinical research and studies with young participants.

AWKNF

3 minute read

Braxia Scientific Q2 2023 Financial Results: Health Clinic Ketamine Treatments Increases 34.5% YoY

By Joana Scopel

Today, 3:00 AM

Braxia Scientific Corp., (CSE: BRAX) (OTC: BRAXF) (FWB: 4960), a medical research and telemedicine company with clinics providing innovative ketamine and psilocybin treatments for depression and related disorders, announced the filing of its financial statements and management discussion and analysis for the

BRAXF

4 minute read

Psyched: CA’s Psychedelic-Assisted Treatments, Ketamine Therapy, Near-Death Experience And More

By Lara Goldstein

Today, 3:00 AM

Alberta Becomes The First Canadian Province To Regulate Psychedelics-Assisted Therapy

ATAI

3 minute read

Ketamine Therapy At Your Doorstep, Growing Number Of Clinics Offer This Treatment Option

By Lara Goldstein

Today, 3:00 AM

Being the sole psychedelic legally available as medicine, ketamine-assisted therapy services are expanding at a rapid pace across the U.S.

BRAXF

4 minute read

Great Psychedelics And Business Events Are Coming In Q4: Check Them Out Here

By Lara Goldstein

Today, 3:00 AM

The season for psychedelics conferences is right around the corner. From very large and well-known events to small meets, this year’s remaining months are loaded with on-site and virtual discussions around the natural plant and synthetic medicines revolutionizing mental health.

ATAI